Product Program year 2025 Source: CMS Open Payments

Iovera

Device Pain Management

PDI 00816287020071

Open in the dashboard

General payments

$7,387,863

31,682 payments

Research payments

$485,451

275 payments

Through program year 2025, $7,387,863 in general payments and $485,451 in research payments were reported against Iovera (Pain Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $1,755,130 6,462
2025 Research $199,032 167
2024 General $1,778,514 9,226
2024 Research $286,418 108
2023 General $2,632,570 11,735
2022 General $1,221,649 4,259

Breakdown

Who paid General payments · program years 2022–2025
  1. Pacira Pharmaceuticals Incorporated $7,387,863 31,682 payments
Top recipients General payments · program year 2025
  1. Vinod Dasa Orthopaedic Surgery · Kenner, LA $119,848 7% · 88 payments
  2. Karina Gritsenko Anesthesiology · Bronx, NY $110,340 6% · 117 payments
  3. Christopher Varacallo Family Medicine · Du Bois, PA $105,693 6% · 83 payments
  4. Gary Schwartz Pain Medicine · Brooklyn, NY $105,453 6% · 86 payments
  5. Nirav Amin Orthopaedic Surgery · Placentia, CA $74,983 4% · 24 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Anesthesiology $459,626 26% · 301 practitioners
  2. Orthopaedic Surgery $290,653 17% · 410 practitioners
  3. Physical Medicine & Rehabilitation $167,924 10% · 169 practitioners
  4. Pain Medicine Anesthesiology $142,774 8% · 76 practitioners
  5. Family Medicine $112,128 6% · 52 practitioners

The top 5 of 99 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $190,880 11% · 74 recipients
  2. California $184,129 10% · 81 recipients
  3. Louisiana $172,055 10% · 218 recipients
  4. Florida $156,584 9% · 301 recipients
  5. Pennsylvania $141,078 8% · 107 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

31,682 general · 275 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record